Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Calcium Dobesilate × Clear all

Sponsor

Conditions

Multiple Myeloma 107 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Recurrence 20 Leukemia 18 Burkitt Lymphoma 18 Lymphoma 17 Neoplasms, Plasma Cell 13 Lymphoma, Non-Hodgkin 13 Nausea 12 Lymphoma, Mantle-Cell 12 Vomiting 11 Waldenstrom Macroglobulinemia 10 Breast Neoplasms 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Neoplasms 9 Lymphoma, Follicular 9 Immunoglobulin Light-chain Amyloidosis 8 Lymphoma, B-Cell, Marginal Zone 7 Hodgkin Disease 7 Amyloidosis 7 Smoldering Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Prostatic Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Hematologic Neoplasms 5 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Cutaneous 4

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 pembrolizumab 1 ioflupane 1 idelalisib 1 aflibercept 1 Water 1 Vertical Dimension 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡